Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Zai Lab Ltd ( (HK:9688) ) has provided an announcement.
Zai Lab Ltd has announced its 2025 annual general meeting of shareholders, scheduled for June 18, 2025, in Shanghai and virtually. The meeting will address several key resolutions, including the re-election of directors, the appointment of KPMG as auditors, and the approval of executive compensation and share issuance mandates, which are crucial for the company’s governance and strategic planning.
More about Zai Lab Ltd
Zai Lab Ltd is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapies. The company is listed on the Hong Kong Stock Exchange and is involved in the healthcare sector, aiming to address significant unmet medical needs.
YTD Price Performance: 11.48%
Average Trading Volume: 400
Technical Sentiment Signal: Sell
Current Market Cap: €3.08B
For an in-depth examination of 9688 stock, go to TipRanks’ Stock Analysis page.